Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Alpelisib Patent Expiration

Alpelisib was first introduced by Novartis Pharmaceuticals Corp in its drug Piqray on May 24, 2019. Another drug containing Alpelisib is Vijoice.


Alpelisib Patents

Given below is the list of patents protecting Alpelisib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Piqray US8227462 Pyrrolidine-1,2-dicarboxamide derivatives Apr 29, 2033 Novartis
Piqray US8476268 Pyrrolidine-1,2-dicarboxamide derivatives Sep 10, 2029 Novartis
Vijoice US8227462 Pyrrolidine-1,2-dicarboxamide derivatives Apr 29, 2033 Novartis
Vijoice US8476268 Pyrrolidine-1,2-dicarboxamide derivatives Sep 10, 2029 Novartis


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳